Plethora files PE drug in Europe, hoping penis number will find global partner
This article was originally published in Scrip
Executive Summary
Plethora Solutions, a UK-based sexual health specialty pharma, has submitted a dossier to the European Medicines Agency (EMA) for the approval of PSD502 for the treatment of premature ejaculation.